Processa Pharmaceuticals, Inc. Amortization of Debt Discount (Premium)
Processa Pharmaceuticals, Inc. (PCSA) reported Amortization of Debt Discount (Premium) of $23.37 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2018-04-16
- Processa Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2016-12-31 was -$967.00, a 106.52% decline year-over-year.
- Processa Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2016-03-31 was $967.00, a 93.33% decline year-over-year.
- Processa Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2017 was $23.37K.
- Processa Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Processa Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2015 was $58.80K, a 61.72% decline from fiscal 2014.
- Processa Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2014 was $153.62K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 12 month as first filed | Amortization of Debt Discount (Premium) 36 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $23.37K 10-K · filed 2018-04-16 | |||||
| 2016-12-31 | -$967.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-16 | -$967.00 derived: sum of 2 quarters · filed 2018-04-16 | -$967.00 derived: sum of 3 quarters · filed 2018-04-16 | $0.00 10-K · filed 2018-04-16 | $967.00 10-K · filed 2017-09-25 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $0.00 derived: sum of 2 quarters · filed 2017-11-20 | $967.00 10-Q · filed 2017-11-20 | $15.79K derived: sum of 4 quarters · filed 2017-11-20 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | $967.00 10-Q · filed 2017-10-04 | $15.79K derived: sum of 3 quarters · filed 2017-10-04 | $30.61K derived: sum of 4 quarters · filed 2017-10-04 | ||
| 2016-03-31 | $967.00 10-Q · filed 2017-10-04 | $15.79K derived: sum of 2 quarters · filed 2017-10-04 | $30.61K derived: sum of 3 quarters · filed 2017-10-04 | $45.27K derived: sum of 4 quarters · filed 2017-10-04 | ||
| 2015-12-31 | $14.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $29.64K derived: sum of 2 quarters · filed 2017-09-25 | $44.30K derived: sum of 3 quarters · filed 2017-09-25 | $58.80K 10-K · filed 2017-09-25 | ||
| 2015-09-30 | $14.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $29.48K derived: sum of 2 quarters · filed 2017-09-08 | $43.98K 10-Q · filed 2017-09-08 | $66.90K derived: sum of 4 quarters · filed 2017-09-08 | ||
| 2015-06-30 | $14.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $29.16K 10-Q · filed 2017-08-30 | $52.08K derived: sum of 3 quarters · filed 2017-08-30 | $110.42K derived: sum of 4 quarters · filed 2017-08-30 | ||
| 2015-03-31 | $14.50K 10-Q · filed 2017-08-07 | $37.41K derived: sum of 2 quarters · filed 2017-08-07 | $95.76K derived: sum of 3 quarters · filed 2017-08-07 | $147.03K derived: sum of 4 quarters · filed 2017-08-07 | ||
| 2014-12-31 | $22.92K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $81.26K derived: sum of 2 quarters · filed 2017-06-19 | $132.53K derived: sum of 3 quarters · filed 2017-06-19 | $153.62K 10-K · filed 2017-06-19 | ||
| 2014-09-30 | $58.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $109.61K derived: sum of 2 quarters · filed 2015-12-01 | $130.70K 10-Q · filed 2015-12-01 | |||
| 2014-06-30 | $51.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $72.36K 10-Q · filed 2015-08-19 | ||||
| 2014-03-31 | $21.09K 10-Q · filed 2015-05-15 | $21.09K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |